Related Experiment Video
Updated: Aug 23, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide
Netta Levin1, John Moshe Gomori, Tali Siegal
1Leslie & Michael Gaffin Center for Neuro-Oncology and the Neuro-Imaging Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel. imbar_l@netvision.net.il
Abstract:
The optimal therapy for gliomatosis cerebri is unclear, and the rate of response to chemotherapy is not known. Eleven radiotherapy-naive patients received a median number of 10 treatment cycles of temozolomide. An objective response was documented in 45%, and the median time to tumor progression was 13 months with a progression-free survival of 55% at 12 months. These results indicate that radiotherapy to extensive brain regions can be deferred until progressive disease is observed.

